These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 4150557

  • 1. Proceedings: The effect of formulation on the availability of sulphadiazine.
    Garnham JC, Raymond K, Shotton E, Turner P.
    J Pharm Pharmacol; 1973 Dec; 25():Suppl:151P-152. PubMed ID: 4150557
    [No Abstract] [Full Text] [Related]

  • 2. Influence of magnesium stearate on the dissolution and biological availability of sulphadiazine tablet formulations [proceedings].
    Ahmed M, Enever RP.
    J Pharm Pharmacol; 1976 Dec; 28 Suppl():5P. PubMed ID: 12326
    [No Abstract] [Full Text] [Related]

  • 3. [Formulation of tablets and bioavailability: a biologic method of evaluation].
    Lévy-Appert-Collin M, Willemin JC, Lévy J.
    Pharm Acta Helv; 1976 Dec; 51(11):348-51. PubMed ID: 1019179
    [No Abstract] [Full Text] [Related]

  • 4. Drug formulation and biologic availability.
    Poole JW.
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract] [Full Text] [Related]

  • 5. Recent advances in tablet technology.
    Cooper J.
    Adv Pharm Sci; 1971 Sep; 3():1-106. PubMed ID: 4947390
    [No Abstract] [Full Text] [Related]

  • 6. Studies on the physiological availability and metabolism of sulfonamides. I. Sulfadiazine.
    Van Petten GR, Becking GC, Withey RJ, Lettau HF.
    J Clin Pharmacol New Drugs; 1971 Sep; 11(1):27-34. PubMed ID: 4926393
    [No Abstract] [Full Text] [Related]

  • 7. [Biopharmaceutics and drug formulation].
    Riccieri FM.
    Ann Ist Super Sanita; 1982 Sep; 18(3):541-6. PubMed ID: 7187842
    [No Abstract] [Full Text] [Related]

  • 8. Effect of certain tablet formulation factors on the antimicrobial activity of tetracycline hydrochloride and chloramphenicol. 2. Effect of disintegrants.
    Asker A, el-Nakeeb M, Motawi M, el-Gindy N.
    Pharmazie; 1973 Jul; 28(7):474-6. PubMed ID: 4767500
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serum concentrations of trimethoprim and sulfadiazine following oral paste administration to the horse.
    Sigel CW, Byars TD, Divers TJ, Murch O, DeAngelis D.
    Am J Vet Res; 1981 Nov; 42(11):2002-5. PubMed ID: 7337298
    [Abstract] [Full Text] [Related]

  • 13. [Effect of various factors on in vitro output velocity from delayed-action tablets 1. Tetracycline delayed-action tablets].
    Tomassini L, Naplatanova D.
    Pharmazie; 1973 Jul; 28(7):447-9. PubMed ID: 4767491
    [No Abstract] [Full Text] [Related]

  • 14. Use of a calf salmonellosis model to evaluate the therapeutic properties of trimethoprim and sulphadiazine and their mutual potentiation in vivo.
    White G, Piercy DW, Gibbs HA.
    Res Vet Sci; 1981 Jul; 31(1):27-31. PubMed ID: 7313315
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A model for short term drug absorption studies; comparison of sulphadiazine tablets.
    Saunders L, Ahmed M, Enever RP, Natunen T.
    J Pharm Pharmacol; 1978 Jan; 30(1):11-4. PubMed ID: 22718
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.